Latest Insider Transactions at Acutus Medical, Inc. (AFIB)
This section provides a real-time view of insider transactions for Acutus Medical, Inc. (AFIB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Acutus Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Acutus Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Takeo Mukai CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,475
-10.42%
|
$0
$0.21 P/Share
|
|
Feb 06
2024
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,582
-6.73%
|
$0
$0.17 P/Share
|
|
Feb 01
2024
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,709
-4.83%
|
$0
$0.19 P/Share
|
|
Feb 01
2024
|
Takeo Mukai CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,869
-3.41%
|
$0
$0.19 P/Share
|
|
Jan 07
2024
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,086
-6.76%
|
$0
$0.19 P/Share
|
|
Jan 07
2024
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
6,342
-9.4%
|
$0
$0.19 P/Share
|
|
Sep 01
2023
|
Takeo Mukai CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,729
-2.01%
|
$0
$0.49 P/Share
|
|
Aug 05
2023
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.2%
|
$0
$0.69 P/Share
|
|
Aug 05
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-0.36%
|
$0
$0.69 P/Share
|
|
Aug 02
2023
|
Takeo Mukai CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-0.6%
|
-
|
|
Aug 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,484
-1.79%
|
-
|
|
Aug 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+14.42%
|
-
|
|
Jun 15
2023
|
James E Flynn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8,400
+28.75%
|
-
|
|
Jun 15
2023
|
Niamh Louise Pellegrini Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.6%
|
-
|
|
Jun 15
2023
|
Jason K Garland Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+27.27%
|
-
|
|
Jun 15
2023
|
Andrew El Bardissi Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.75%
|
-
|
|
Jun 15
2023
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,920
+33.33%
|
-
|
|
Jun 15
2023
|
David P Bonita Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.75%
|
-
|
|
Jun 15
2023
|
John F Sheridan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+25.65%
|
-
|
|
Jun 15
2023
|
Shaden Marzouk Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+28.75%
|
-
|
|
Jun 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,290
-4.55%
|
$0
$0.85 P/Share
|
|
Apr 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-0.86%
|
$0
$0.75 P/Share
|
|
Apr 01
2023
|
Charlie Piscitello SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-0.99%
|
$0
$0.75 P/Share
|
|
Apr 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,165
-0.83%
|
$0
$0.75 P/Share
|
|
Apr 01
2023
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
321
-0.48%
|
$0
$0.75 P/Share
|
|
Mar 01
2023
|
Charlie Piscitello SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+32.94%
|
-
|
|
Mar 01
2023
|
Takeo Mukai CFO |
BUY
Grant, award, or other acquisition
|
Direct |
47,500
+36.14%
|
-
|
|
Mar 01
2023
|
David Roman President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+26.05%
|
-
|
|
Mar 01
2023
|
Kevin Mathews SVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+38.94%
|
-
|
|
Mar 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+29.91%
|
-
|
|
Feb 01
2023
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
3,540
-12.78%
|
$3,540
$1.87 P/Share
|
|
Feb 01
2023
|
David Roman President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,196
-3.95%
|
$10,196
$1.87 P/Share
|
|
Feb 01
2023
|
Takeo Mukai CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,855
-7.26%
|
$2,855
$1.87 P/Share
|
|
Feb 01
2023
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,525
-10.24%
|
$6,525
$1.87 P/Share
|
|
Feb 01
2023
|
Charlie Piscitello SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,627
-13.08%
|
$6,627
$1.87 P/Share
|
|
Oct 01
2022
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,520
+18.75%
|
-
|
|
Sep 01
2022
|
Jason K Garland Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+50.0%
|
-
|
|
Sep 01
2022
|
Takeo Mukai CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.73%
|
-
|
|
Aug 05
2022
|
Charlie Piscitello SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-0.87%
|
$433
$1.56 P/Share
|
|
Aug 05
2022
|
Tom Sohn SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-0.68%
|
$433
$1.56 P/Share
|
|
Aug 05
2022
|
Kevin Mathews SVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.48%
|
$134
$1.56 P/Share
|
|
Aug 01
2022
|
David Roman President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+22.5%
|
-
|
|
Jun 16
2022
|
James E Flynn Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8,400
+40.34%
|
-
|
|
Jun 16
2022
|
David P Bonita Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.34%
|
-
|
|
Jun 16
2022
|
Andrew El Bardissi Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.34%
|
-
|
|
Jun 16
2022
|
Daniella Cramp Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+41.95%
|
-
|
|
Jun 16
2022
|
John F Sheridan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+34.5%
|
-
|
|
Jun 16
2022
|
Niamh Louise Pellegrini Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+40.05%
|
-
|
|
Jun 16
2022
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+50.0%
|
-
|
|
Jun 16
2022
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,400
+12.05%
|
-
|